title: Isoosmolar enemas demonstrate preferential gastrointestinal distribution, safety, and acceptability compared with hyperosmolar and hypoosmolar enemas as a potential delivery vehicle for rectal microbicides.
abstract: Rectally applied antiretroviral microbicides for preexposure prophylaxis (PrEP) of HIV infection are currently in development. Since enemas (rectal douches) are commonly used by men who have sex with men prior to receptive anal intercourse, a microbicide enema could enhance PrEP adherence by fitting seamlessly within the usual sexual practices. We assessed the distribution, safety, and acceptability of three enema types-hyperosmolar (Fleet), hypoosmolar (distilled water), and isoosmolar (Normosol-R)-in a crossover design. Nine men received each enema type in random order. Enemas were radiolabeled [(99m)Tc-diethylene triamine pentaacetic acid (DTPA)] to assess enema distribution in the colon using single photon emission computed tomography/computed tomography (SPECT/CT) imaging. Plasma (99m)Tc-DTPA indicated mucosal permeability. Sigmoidoscopic colon tissue biopsies were taken to assess injury as well as tissue penetration of the (99m)Tc-DTPA. Acceptability was assessed after each product use and at the end of the study. SPECT/CT imaging showed that the isoosmolar enema had greater proximal colonic distribution (up to the splenic flexure) and greater luminal and colon tissue concentrations of (99m)Tc-DTPA when compared to the other enemas (p<0.01). Colon biopsies also showed that only the hyperosmolar enema caused sloughing of the colonic epithelium (p<0.05). In permeability testing, the hypoosmolar enema had higher plasma (99m)Tc-DTPA 24-h area under the concentration-time curve and peak concentration compared to the hyperosmolar and isoosmolar enemas, respectively. Acceptability was generally good with no clear preferences among the three enema types. The isoosmolar enema was superior or similar to the other enemas in all categories and is a good candidate for further development as a rectal microbicide vehicle.
authors.affiliation: 1 Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland.
authors.forename: Francisco J
authors.initials: FJ
authors.lastname: Leyva
authors.forename: Rahul P
authors.initials: RP
authors.lastname: Bakshi
authors.forename: Edward J
authors.initials: EJ
authors.lastname: Fuchs
authors.forename: Liye
authors.initials: L
authors.lastname: Li
authors.forename: Brian S
authors.initials: BS
authors.lastname: Caffo
authors.forename: Arthur J
authors.initials: AJ
authors.lastname: Goldsmith
authors.forename: Ana
authors.initials: A
authors.lastname: Ventuneac
authors.forename: Alex
authors.initials: A
authors.lastname: Carballo-Diéguez
authors.forename: Yong
authors.initials: Y
authors.lastname: Du
authors.forename: Jeffrey P
authors.initials: JP
authors.lastname: Leal
authors.forename: Linda A
authors.initials: LA
authors.lastname: Lee
authors.forename: Michael S
authors.initials: MS
authors.lastname: Torbenson
authors.forename: Craig W
authors.initials: CW
authors.lastname: Hendrix
mesh_terms: D000890:Anti-Infective Agents / Q000008:administration & dosage*; D001706:Biopsy; D012809:Colon, Sigmoid / Q000187:drug effects / Q000473:pathology; D004733:Enema / Q000009:adverse effects* / Q000379:methods*; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D007413:Intestinal Mucosa / Q000187:drug effects / Q000473:pathology; D008297:Male; D010342:Patient Acceptance of Health Care; D012996:Solutions / Q000008:administration & dosage* / Q000737:chemistry* / Q000493:pharmacokinetics; D015899:Tomography, Emission-Computed, Single-Photon
chemical_list: D000890:Anti-Infective Agents; D012996:Solutions